Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria.
about
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic childrenIncreased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese miceNewly cultured bacteria with broad diversity isolated from eight-week continuous culture enrichments of cow feces on complex polysaccharides.Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavonesMicroencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 ratsMicrobiota and metabolome associated with immunoglobulin A nephropathy (IgAN).Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.Different Intestinal Microbial Profile in Over-Weight and Obese Subjects Consuming a Diet with Low Content of Fiber and AntioxidantsGenomic insights into bifidobacteriaHighlighting new phylogenetic specificities of Crohn's disease microbiota.The establishment of the infant intestinal microbiome is not affected by rotavirus vaccinationThe beneficial effect of exopolysaccharides from Bifidobacterium bifidum WBIN03 on microbial diversity in mouse intestine.Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specifiedComparative phenotypic and molecular genetic profiling of wild Lactococcus lactis subsp. lactis strains of the L. lactis subsp. lactis and L. lactis subsp. cremoris genotypes, isolated from starter-free cheeses made of raw milkEvaluation of the prebiotic potential of arabinoxylans from brewer's spent grain.Human colon-derived soluble factors modulate gut microbiota composition.Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota.Differential Metabolism of Exopolysaccharides from Probiotic Lactobacilli by the Human Gut Symbiont Bacteroides thetaiotaomicronDifferent metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteriaBacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria.Effects of Pediococcus parvulus 2.6 and its exopolysaccharide on plasma cholesterol levels and inflammatory markers in mice.Oral administration of live exopolysaccharide-producing Pediococcus parvulus, but not purified exopolysaccharide, suppressed Enterobacteriaceae without affecting bacterial diversity in ceca of mice.Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp.Bioengineered probiotics, a strategic approach to control enteric infectionsFour cases of bacteremia caused by Oscillibacter ruminantium, a newly described speciesDesigning probiotics with respect to the native microbiome.Bifidobacterium breve UCC2003 surface exopolysaccharide production is a beneficial trait mediating commensal-host interaction through immune modulation and pathogen protection.Sugar-coated: exopolysaccharide producing lactic acid bacteria for food and human health applications.Production, properties, and industrial food application of lactic acid bacteria-derived exopolysaccharides.A proteomic approach towards understanding the cross talk between Bacteroides fragilis and Bifidobacterium longum in coculture.Effects of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on the IgA flow rate of saliva in elderly persons residing in a nursing home: A before-after non-randomised intervention study.Exopolysaccharide from Lactobacillus fermentum Lf2 and its functional characterization as a yogurt additive.Probiotic properties of the 2-substituted (1,3)-beta-D-glucan-producing bacterium Pediococcus parvulus 2.6.Interactions between Bifidobacterium and Bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria.Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders - a pilot study.Impact on human health of microorganisms present in fermented dairy products: an overview.Insight into the Functionality of Microbial Exopolysaccharides by NMR Spectroscopy and Molecular Modeling.Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury.Bifidogenic effect and stimulation of short chain fatty acid production in human faecal slurry cultures by oligosaccharides derived from lactose and lactulose.Degenerate PCR primers for detecting putative priming glycosyltransferase genes in Bifidobacterium strains.
P2860
Q21132990-DF53325F-09AD-4D99-B019-E4C1E762E53FQ28730963-A3A65110-2EEA-4F5C-B03D-35926612F383Q30691690-696E4906-BBB8-458D-AFC4-DF7CF552DF75Q33568579-FB1F25EC-AA95-467B-B9CE-2F83CD7402FEQ33746322-4DD74179-8B38-466D-A4C6-901002FA3965Q33748498-D51A3F62-BD10-4301-BCB5-5308FB9AC098Q33779212-AA046C79-1E31-47D3-A5B6-D5B95951A5CFQ33851830-73BA1639-18CB-4D4F-AD9B-7AC95F0EA99DQ34119622-76317E63-2A8F-4A25-A342-70D7584D7912Q34132092-4A9E6894-6B70-4501-8914-4D3E1A4E8EA3Q34664949-F5E0D47B-428F-4771-97AA-08FFC0D3B22DQ34743579-1DBCB68F-983F-4F8A-B82A-C500E7E35560Q35018672-48E99529-6F28-4A7C-8ED0-F8B4B79E3948Q35139091-BF8F00D9-7D80-459C-A642-170EEBD70B36Q35223730-3A36A1D0-72F7-4388-9C60-72B1192B3CAEQ35383897-9EE9721D-7EA2-413B-B723-BDEEBE218403Q35559924-E9B97546-C746-4DF5-B8FE-8A491F88E386Q35914087-E9597D35-47B4-49B5-96C7-82C729A9239BQ35964240-A14A4A06-B736-4EA3-900C-5EEAE64460C1Q36078273-2490D251-F2CC-45F1-8392-949B70DF92D2Q36575435-C771C145-4E2B-4152-A44F-5D63683D1D7EQ37125327-884D8F40-E9FB-4D7A-AC1F-D661256B000CQ37545212-0DA315EB-7EF7-4472-B7CB-2E573D0978B9Q37607761-49EC37BC-088A-43B5-914D-B3AFA53C2A1FQ37713418-3395B1B4-537F-47EE-A904-8BC33E77E7E2Q38008468-A0E3A5FA-673E-42A0-89A2-7E36D10FE75FQ38020020-B642F8EB-8689-40DD-9B87-4C6AED6AF3F3Q38314990-663B9734-96C2-4CC2-A5FE-6303986318CDQ38654303-7C4A3A4F-720B-47C1-86D2-17DFDF1D31BAQ39785370-DA6FBAC5-36D0-4C73-87B0-F35E9BEC034FQ40081608-4F6D30E9-FE26-482C-B832-82EB3191D82AQ40451907-8738B6D3-0AF3-4C94-853C-DE4FB9BA12F5Q41828968-E5E6E143-2D6C-4A6B-A2F2-B08EA9AEAEB5Q41995475-DC32153A-E54D-49B3-8AE0-6400F027979DQ42148788-B9EFB900-9476-487C-AD9A-79FBF21DCAD7Q42150833-E0D7BBE4-1E66-4A7C-84CE-4B331079E44DQ42644157-DA16BDFD-C0D1-4738-A722-8A8A6990894BQ45993142-236F35B3-175C-4CBE-BF51-329F57F350FFQ46007324-B874F429-D706-47D3-9454-95E1617F289AQ46777340-F82F5242-6B61-497E-81B2-84928325A3F7
P2860
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Exopolysaccharides produced by ...... for human intestinal bacteria.
@en
type
label
Exopolysaccharides produced by ...... for human intestinal bacteria.
@en
prefLabel
Exopolysaccharides produced by ...... for human intestinal bacteria.
@en
P2093
P2860
P50
P356
P1476
Exopolysaccharides produced by ...... for human intestinal bacteria
@en
P2093
Ana María Hernández-Barranco
Clara G de los Reyes-Gavilán
Miguel Gueimonde
Nuria Salazar
Patricia Ruas-Madiedo
P2860
P304
P356
10.1128/AEM.00325-08
P407
P50
P577
2008-06-06T00:00:00Z